Penserra Capital Management LLC Karuna Therapeutics, Inc. Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$110.64 - $159.4 $74,682 - $107,595	-675 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$101.2 - $125.87 $506 - $629	5 Added 0.75%	675 $82,000
Q2 2021 Aug 12, 2021	BUY	$107.45 - $135.95 $6,447 - $8,156	60 Added 9.84%	670 $76,000
Q1 2021 May 13, 2021	SELL	$95.46 - $133.08 $954 - $1,330	-10 Reduced 1.61%	610 $73,000
Q4 2020 Feb 12, 2021	BUY	$75.23 - $109.23 $29,490 - $42,818	392 Added 171.93%	620 $62,000
Q3 2020 Nov 13, 2020	BUY	$71.31 - $109.74 $16,258 - $25,020	228 New	228 $17,000

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.